Jeff Yass’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,000
Closed -$296K 13507
2024
Q1
$296K Buy
+7,000
New +$295K ﹤0.01% 9721
2019
Q2
Sell
-2,100
Closed -$227K 10974
2019
Q1
$227K Buy
+2,100
New +$209K ﹤0.01% 7690
2018
Q3
Sell
-2,600
Closed -$301K 10448
2018
Q2
$301K Buy
+2,600
New +$286K ﹤0.01% 7843
2018
Q1
Sell
-2,200
Closed -$230K 10369
2017
Q4
$230K Buy
+2,200
New +$242K ﹤0.01% 8029
2017
Q3
Sell
-1,900
Closed -$213K 9794
2017
Q2
$213K Buy
+1,900
New +$215K ﹤0.01% 8187
2017
Q1
Sell
-3,400
Closed -$358K 10193
2016
Q4
$358K Sell
3,400
-5,200
-60% -$545K ﹤0.01% 7630
2016
Q3
$950K Sell
8,600
-5,800
-40% -$768K ﹤0.01% 4910
2016
Q2
$2.1M Buy
14,400
+9,800
+213% +$1.39M ﹤0.01% 3490
2016
Q1
$659K Sell
4,600
-12,000
-72% -$1.7M ﹤0.01% 5903
2015
Q4
$2.57M Buy
16,600
+8,500
+105% +$1.24M ﹤0.01% 3584
2015
Q3
$1.16M Sell
8,100
-33,100
-80% -$4.63M ﹤0.01% 5420
2015
Q2
$5.92M Sell
41,200
-3,300
-7% -$471K ﹤0.01% 2659
2015
Q1
$6.28M Buy
44,500
+37,100
+501% +$5.71M ﹤0.01% 2424
2014
Q4
$1.1M Buy
7,400
+5,600
+311% +$823K ﹤0.01% 5682
2014
Q3
$277K Sell
1,800
-3,500
-66% -$527K ﹤0.01% 8149
2014
Q2
$743K Buy
+5,300
New +$588K ﹤0.01% 6680

Other funds holding TARO

Jeff Yass's TARO Position: Q1 2024 in Review

Jeff Yass sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 6,668 shares — an estimated $281K sold.

Jeff Yass first reported a position in TARO in Q2 2014 and held it in 22 quarters. The position peaked at $5.1M in Q4 2017. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Jeff Yass reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • Jeff Yass sold 6,668 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $281K.
  • Jeff Yass first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 22 quarters.
  • Jeff Yass's Taro Pharmaceutical Industries Ltd. position peaked at $5.1M in Q4 2017.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.